Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy
Clinical trial NCT05790096 · UNKNOWN
Trial details
- NCT number
- NCT05790096
- Sponsor
- Blau Farmaceutica S.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.